Huntsman Corporation (NASDAQ:HUN) Files An 8-K Completion of Acquisition or Disposition of Assets

Item 2.01 Completion of Disposition of Assets.

On December30, 2016, Huntsman Investments (Netherlands) BV
(HIBV), a wholly-owned subsidiary of Huntsman Corporation (the
Company), completed the previously announced sale of HIBVs
European surfactants manufacturing facilities and related assets
for an enterprise value of $225 million to Innospec International
LTD (Innospec), a wholly-owned subsidiary of Innospec Inc., to
the Share and Asset Purchase Agreement entered into by and
between HIBV and Innospec dated October25, 2016, which was
amended and restated on December22, 2016 to make minor
clarifications (the Agreement).

The Agreement contains customary representations, warranties, and
covenants and provides for indemnification rights with respect to
a breach of a representation, warranty or covenant by either
party, as well as for other specified matters.

The foregoing description of the terms of the Agreement is
qualified in its entirety by reference to the Agreement, a copy
of which is attached hereto as Exhibit2.1 and is incorporated
into this report by reference.

The Agreement has been included to provide investors and security
holders with information regarding its terms. It is not intended
to provide any other factual information about the Company or
HIBV. The representations, warranties and covenants contained in
the Agreement were made only for purposes of the Agreement and as
of specific dates, were solely for the benefit of the parties to
the Agreement, and may be subject to limitations agreed upon by
the contracting parties, including being qualified by
confidential disclosures exchanged between the parties in
connection with the execution of the Agreement. The
representations and warranties may have been made for the
purposes of allocating contractual risk between the parties to
the Agreement instead of establishing these matters as facts, and
may be subject to standards of materiality applicable to the
contracting parties that differ from those applicable to
investors.

Item 7.01 Regulation FD.

In connection with the completion of the transaction referred to
in Item 2.01 above, on December30, 2016, the Company issued a
press release. The press release is attached herewith as
Exhibit99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.